|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.20 EUR | -1.01% |
|
+7.62% | +19.34% |
| 06-09 | European markets rally - Chipmakers and banks in demand | RE |
| 06-09 | Symrise tops DAX as analysts turn bullish on Givaudan as well | DP |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.56 | 5.35 | 4.29 | 5.48 | 4.7 | |||||
Return on Total Capital | 7.37 | 6.89 | 5.4 | 6.92 | 5.89 | |||||
Return On Equity % | 13.72 | 8.47 | 9.45 | 12.51 | 6.53 | |||||
Return on Common Equity | 13.66 | 8.31 | 9.48 | 12.56 | 6.48 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 38.66 | 36.85 | 35.78 | 39.28 | 37.63 | |||||
SG&A Margin | 20.38 | 20.25 | 20.12 | 19.95 | 20.16 | |||||
EBITDA Margin % | 21.23 | 19.65 | 16.78 | 19.44 | 14.93 | |||||
EBITA Margin % | 17.58 | 16.11 | 13.72 | 16.35 | 14.49 | |||||
EBIT Margin % | 14.63 | 13.39 | 11.33 | 14.19 | 12.37 | |||||
Income From Continuing Operations Margin % | 10.06 | 6.29 | 7.29 | 9.64 | 5.14 | |||||
Net Income Margin % | 9.8 | 6.06 | 7.2 | 9.57 | 5.06 | |||||
Net Avail. For Common Margin % | 9.8 | 6.06 | 7.2 | 9.57 | 5.06 | |||||
Normalized Net Income Margin | 8.26 | 5.69 | 6.07 | 8.04 | 5.01 | |||||
Levered Free Cash Flow Margin | 7.04 | 1.59 | 6.6 | 10.35 | 4.65 | |||||
Unlevered Free Cash Flow Margin | 7.68 | 2.38 | 7.85 | 11.33 | 5.65 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.64 | 0.61 | 0.62 | 0.61 | |||||
Fixed Assets Turnover | 3.03 | 3.2 | 2.92 | 2.92 | 2.99 | |||||
Receivables Turnover (Average Receivables) | 5.75 | 5.82 | 5.49 | 5.53 | 5.2 | |||||
Inventory Turnover (Average Inventory) | 2.54 | 2.52 | 2.35 | 2.39 | 2.61 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.04 | 2.76 | 2.89 | 1.61 | 2.52 | |||||
Quick Ratio | 1.07 | 1.34 | 1.5 | 0.92 | 1.61 | |||||
Operating Cash Flow to Current Liabilities | 0.46 | 0.37 | 0.77 | 0.46 | 0.59 | |||||
Days Sales Outstanding (Average Receivables) | 63.48 | 62.67 | 66.53 | 66.13 | 70.17 | |||||
Days Outstanding Inventory (Average Inventory) | 143.93 | 145.01 | 155.21 | 153.1 | 139.64 | |||||
Average Days Payable Outstanding | 55.15 | 52.85 | 62.7 | 59.37 | 59.18 | |||||
Cash Conversion Cycle (Average Days) | 152.26 | 154.83 | 159.04 | 159.86 | 150.63 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 55.37 | 70.56 | 69.41 | 63.33 | 70.29 | |||||
Total Debt / Total Capital | 35.64 | 41.37 | 40.97 | 38.78 | 41.28 | |||||
LT Debt/Equity | 43.82 | 69.06 | 67.7 | 41.02 | 58.67 | |||||
Long-Term Debt / Total Capital | 28.2 | 40.49 | 39.96 | 25.11 | 34.45 | |||||
Total Liabilities / Total Assets | 51.04 | 53.61 | 53.02 | 51.71 | 52.65 | |||||
EBIT / Interest Expense | 14.4 | 10.49 | 5.66 | 9.05 | 7.73 | |||||
EBITDA / Interest Expense | 21.45 | 15.86 | 8.7 | 12.82 | 9.8 | |||||
(EBITDA - Capex) / Interest Expense | 17.48 | 11.96 | 6.07 | 9.92 | 7.3 | |||||
Total Debt / EBITDA | 2.16 | 2.73 | 3.11 | 2.53 | 3.4 | |||||
Net Debt / EBITDA | 1.62 | 2.39 | 2.63 | 1.83 | 2.1 | |||||
Total Debt / (EBITDA - Capex) | 2.65 | 3.61 | 4.45 | 3.27 | 4.57 | |||||
Net Debt / (EBITDA - Capex) | 1.98 | 3.17 | 3.77 | 2.36 | 2.81 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.67 | 20.72 | 2.42 | 5.67 | -1.39 | |||||
Gross Profit, 1 Yr. Growth % | 6.35 | 15.1 | -0.56 | 16 | -5.54 | |||||
EBITDA, 1 Yr. Growth % | 15.44 | 21.19 | -4.42 | 22.19 | -24.42 | |||||
EBITA, 1 Yr. Growth % | 18.66 | 22.08 | -6.45 | 25.7 | -12.81 | |||||
EBIT, 1 Yr. Growth % | 24.35 | 24.54 | -5.67 | 32.3 | -14.3 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 22.25 | -24.5 | 18.66 | 39.72 | -47.39 | |||||
Net Income, 1 Yr. Growth % | 22.18 | -25.32 | 21.59 | 40.46 | -47.86 | |||||
Normalized Net Income, 1 Yr. Growth % | 34.17 | -7.48 | 21.83 | 39.82 | -38.73 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 21.49 | -25.93 | 21.59 | 40.46 | -47.86 | |||||
Accounts Receivable, 1 Yr. Growth % | 21.5 | 17.29 | 1.43 | 8.04 | 2.03 | |||||
Inventory, 1 Yr. Growth % | 14.49 | 34.13 | -5.4 | 2.19 | -16.69 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.6 | 18.31 | 6.59 | 4.84 | -11.56 | |||||
Total Assets, 1 Yr. Growth % | 11.83 | 16.63 | 0.8 | 6.11 | -5.06 | |||||
Tangible Book Value, 1 Yr. Growth % | 423.97 | -2.12 | 25.15 | 43.97 | -0.63 | |||||
Common Equity, 1 Yr. Growth % | 38.49 | 11.39 | 2.25 | 9.64 | -6.57 | |||||
Cash From Operations, 1 Yr. Growth % | -17.95 | -30.95 | 99.8 | 24.38 | -13.7 | |||||
Capital Expenditures, 1 Yr. Growth % | 18.1 | 48.92 | 8.3 | -8.62 | -13.48 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -41.31 | -67.96 | 1.9K | 65.59 | -55.78 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -40.69 | -56.48 | 608.8 | 52.39 | -50.91 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.15 | 2.94 | 4.76 | 9.09 | 4.17 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.95 | 14.54 | 11.19 | 4.03 | 2.08 | |||||
Gross Profit, 2 Yr. CAGR % | 4.26 | 10.64 | 6.98 | 7.4 | 4.68 | |||||
EBITDA, 2 Yr. CAGR % | 7.59 | 13.59 | 2.96 | 8.15 | -3.8 | |||||
EBITA, 2 Yr. CAGR % | 7.9 | 14.57 | 3.2 | 8.54 | 4.82 | |||||
EBIT, 2 Yr. CAGR % | 8.81 | 17.21 | 3.89 | 11.75 | 6.63 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 13.69 | -3.93 | -5.35 | 28.76 | -14.26 | |||||
Net Income, 2 Yr. CAGR % | 13.5 | -4.48 | -4.71 | 30.69 | -14.42 | |||||
Normalized Net Income, 2 Yr. CAGR % | 10.39 | 5.65 | 0.54 | 30.57 | -7.3 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 12.89 | -5.17 | -5.02 | 30.69 | -14.42 | |||||
Accounts Receivable, 2 Yr. CAGR % | 6.16 | 19.37 | 9.07 | 4.68 | 4.99 | |||||
Inventory, 2 Yr. CAGR % | 5.26 | 24.04 | 12.64 | -1.68 | -7.73 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.01 | 13.99 | 12.3 | 5.71 | -3.71 | |||||
Total Assets, 2 Yr. CAGR % | 5.63 | 14.47 | 8.43 | 3.42 | 0.37 | |||||
Tangible Book Value, 2 Yr. CAGR % | 324.14 | 122.58 | 10.68 | 34.04 | 19.61 | |||||
Common Equity, 2 Yr. CAGR % | 15.25 | 24.21 | 6.72 | 5.88 | 1.21 | |||||
Cash From Operations, 2 Yr. CAGR % | -2.33 | -24.73 | 17.45 | 57.64 | 3.6 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.06 | 32.62 | 26.99 | -0.52 | -11.08 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 3.99 | -60.05 | 16.86 | 476.3 | -14.32 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 2.19 | -52.85 | 21.18 | 228.75 | -13.41 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.62 | 4.04 | 3.85 | 6.9 | 6.6 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.65 | 10.66 | 10.35 | 9.32 | 2.19 | |||||
Gross Profit, 3 Yr. CAGR % | 6.01 | 7.75 | 6.77 | 9.91 | 2.9 | |||||
EBITDA, 3 Yr. CAGR % | 9.41 | 8.97 | 4.11 | 9.06 | -3.96 | |||||
EBITA, 3 Yr. CAGR % | 8.43 | 8.8 | 4.62 | 10.28 | 0.98 | |||||
EBIT, 3 Yr. CAGR % | 9.65 | 9.36 | 5.99 | 12.63 | 2.38 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.24 | -0.81 | 3.08 | 7.77 | -4.45 | |||||
Net Income, 3 Yr. CAGR % | 10.84 | -1.28 | 3.52 | 8.45 | -3.79 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.77 | 0.45 | 6.83 | 12.25 | 1.57 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 9.09 | -1.92 | 3.08 | 8.21 | -3.79 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.97 | 9.74 | 13.06 | 8.73 | 3.79 | |||||
Inventory, 3 Yr. CAGR % | 5.35 | 14.19 | 13.33 | 9.04 | -6.96 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.43 | 7.95 | 11.46 | 9.75 | -0.39 | |||||
Total Assets, 3 Yr. CAGR % | 10.52 | 9.35 | 9.72 | 7.65 | 0.51 | |||||
Tangible Book Value, 3 Yr. CAGR % | 402.39 | 157.18 | 83.71 | 20.7 | 21.31 | |||||
Common Equity, 3 Yr. CAGR % | 19 | 13.96 | 16.41 | 7.69 | 1.55 | |||||
Cash From Operations, 3 Yr. CAGR % | 5.69 | -12.99 | 4.22 | 19.72 | 28.96 | |||||
Capital Expenditures, 3 Yr. CAGR % | -10.08 | 15 | 23.96 | 13.8 | -5.04 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.56 | -33.5 | -12.05 | 31.29 | 145.09 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 14.64 | -26.85 | -9.14 | 30.83 | 74.54 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.26 | 3.39 | 4.28 | 5.57 | 5.98 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.67 | 9.04 | 8.44 | 7.96 | 6.96 | |||||
Gross Profit, 5 Yr. CAGR % | 4.34 | 6.81 | 6.4 | 7.61 | 5.93 | |||||
EBITDA, 5 Yr. CAGR % | 5.89 | 8.09 | 5.07 | 6.73 | 0.9 | |||||
EBITA, 5 Yr. CAGR % | 5.22 | 7.21 | 4.23 | 7.19 | 4.74 | |||||
EBIT, 5 Yr. CAGR % | 6.36 | 8.14 | 4.77 | 8.46 | 6.26 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.12 | 1.07 | 4.28 | 10.1 | -4.24 | |||||
Net Income, 5 Yr. CAGR % | 8.24 | 0.71 | 4.34 | 10.44 | -4.07 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.7 | 3.02 | 3.75 | 9.15 | 0.96 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6.85 | -0.6 | 3.2 | 10.05 | -4.31 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.68 | 8.96 | 7.8 | 7.69 | 9.76 | |||||
Inventory, 5 Yr. CAGR % | 7.74 | 12.05 | 8.25 | 7.55 | 4.38 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.03 | 11.67 | 10 | 7.05 | 5.13 | |||||
Total Assets, 5 Yr. CAGR % | 6.93 | 10.73 | 9.78 | 6.94 | 5.88 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12.33 | 25.37 | 172.42 | 98.17 | 54.65 | |||||
Common Equity, 5 Yr. CAGR % | 13.78 | 15.7 | 13.93 | 10.65 | 10.07 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.01 | -1.89 | 10.25 | 10.36 | 3.97 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.18 | 4.38 | 3.24 | 8.52 | 8.53 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 36.94 | -13.26 | 12.33 | 15.74 | -12.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 28.98 | -9.08 | 13.76 | 15.02 | -10.86 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.71 | 3.6 | 4.1 | 4.78 | 5.2 |
- Stock Market
- Stocks
- SY1 Stock
- Financials Symrise AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















